ADVERTISEMENT
a person in black shirt and pink pants fumigates a red brick pathway to control mosquitoes in the fight against Dengue virus.
European Medicines Agency Recommends Approving Takeda’s Dengue Vaccine
In clinical trials, the new inoculation demonstrated greater protection for children and people older than 45 than the existing dengue vaccine.
European Medicines Agency Recommends Approving Takeda’s Dengue Vaccine
European Medicines Agency Recommends Approving Takeda’s Dengue Vaccine

In clinical trials, the new inoculation demonstrated greater protection for children and people older than 45 than the existing dengue vaccine.

In clinical trials, the new inoculation demonstrated greater protection for children and people older than 45 than the existing dengue vaccine.

public health, infectious disease, clinical trials

New Malaria Vaccine Shows Most Efficacy of Any to Date: Small Trial
Catherine Offord | Apr 26, 2021 | 3 min read
Immunization had up to 77 percent efficacy in a Phase 2 clinical study of 450 children in Burkina Faso.
The Year in Pathogens
Molly Sharlach | Dec 28, 2014 | 4 min read
Ebola, MERS, and enterovirus D68; polio eradication efforts; new regulations on potentially dangerous research
Ebola Update
Jef Akst | Dec 17, 2014 | 3 min read
Plasma-based therapy trials begin in West Africa; NIH-GSK vaccine shows promise in Phase 1; the real statistics
To Finish Off Polio
Ashley P. Taylor | Jun 16, 2014 | 5 min read
Along with vaccination, antiviral drugs could play a key role in the eradication of poliovirus, but it’s unclear whether today’s candidate therapies will withstand the challenges of the clinic.
The ghost of personalized medicine
Bob Grant | Jun 14, 2011 | 4 min read
Drug therapies tailored to the DNA profiles of individual patients could change the face of medicine, but such treatments aren't commonly used in the clinic.
ADVERTISEMENT